Resilience Capabilities Update July 2026: Fill/Finish

As biologics pipelines grow and delivery formats become more complex, drug product manufacturers are under increasing pressure to balance speed, flexibility, and global supply demands. This session explores how evolving fill-finish, visual inspection, device assembly, and packaging capabilities are helping address these challenges across commercial and late-stage development programs.

Gain insight into the expansion of high-speed prefilled syringe, vial, and cartridge manufacturing capacity, along with the role of isolator-based technologies, in-house analytical testing, and accelerated tech transfer strategies in supporting efficient product commercialization. The discussion also highlights growing investments in device assembly and packaging operations, advances in automated inspection, and the importance of quality-focused, customer-centric manufacturing models.

Whether evaluating outsourcing partners or planning future product launches, attendees will come away with a clearer understanding of the infrastructure.